These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 33707816)

  • 1. Clinicopathological Pattern of Non-lupus Full House Nephropathy.
    Wani AS; Zahir Z; Gupta A; Agrawal V
    Indian J Nephrol; 2020; 30(5):301-306. PubMed ID: 33707816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full-house nephropathy in antinuclear antibody-negative systemic lupus erythematosus: A case report.
    Dhungana R; Bashyal B; Paudel S; Shrestha B; Jha S; Bhurtyal N
    Clin Case Rep; 2024 Aug; 12(8):e9231. PubMed ID: 39086931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rare case of non-lupus full house nephropathy in a transplanted kidney, case report.
    Matarneh AS; Salameh O; Sardar S; Karasinski A; Channapragada T; Abdulbasit M; Washburn E; Ghahramani N
    Clin Case Rep; 2024 May; 12(5):e8886. PubMed ID: 38707603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhinovirus Pneumonia, Rhabdomyolysis-Induced Acute Kidney Injury, and Post-Viral Forme Fruste Lupus.
    Jha VK; Akal RS; Singh BP; Walia GK; B S T; Mahapatra D
    Indian J Nephrol; 2024; 34(4):389-392. PubMed ID: 39156849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SGLT2 inhibitors in lupus nephropathy, a new therapeutic strategy for nephroprotection.
    Morales E; Galindo M
    Ann Rheum Dis; 2022 Aug; 81(9):1337-1338. PubMed ID: 35551062
    [No Abstract]   [Full Text] [Related]  

  • 6. The extent of tubulointerstitial inflammation is an independent predictor of renal survival in lupus nephritis.
    Gomes MF; Mardones C; Xipell M; Blasco M; Solé M; Espinosa G; García-Herrera A; Cervera R; Quintana LF
    J Nephrol; 2021 Dec; 34(6):1897-1905. PubMed ID: 33721269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis.
    Pohlmeyer CW; Shang C; Han P; Cui ZH; Jones RM; Clarke AS; Murray BP; Lopez DA; Newstrom DW; Inzunza MD; Matzkies FG; Currie KS; Di Paolo JA
    BMC Rheumatol; 2021 Mar; 5(1):15. PubMed ID: 33781343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction Of Renal Flare In Adult Patients With Lupus Induced Nephritis.
    Batool H; Naseem T; Shoukat M
    J Ayub Med Coll Abbottabad; 2021; 33(1):9-13. PubMed ID: 33774946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-cell survey of the human glomerulonephritis.
    Chen Z; Zhang T; Mao K; Shao X; Xu Y; Zhu M; Zhou H; Wang Q; Li Z; Xie Y; Yuan X; Ying L; Zhang M; Hu J; Mou S
    J Cell Mol Med; 2021 May; 25(10):4684-4695. PubMed ID: 33754492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis.
    Kianmehr N; Khoshmirsafa M; Shekarabi M; Falak R; Haghighi A; Masoodian M; Seif F; Omidi F; Shirani F; Dadfar N
    J Immunoassay Immunochem; 2021 Jul; 42(4):406-423. PubMed ID: 33788670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement in membranous nephropathy: what we thought we knew and what we really know.
    Cravedi P
    Kidney Int; 2021 Sep; 100(3):499-501. PubMed ID: 33774083
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis.
    Yu KY; Yung S; Chau MK; Tang CS; Yap DY; Tang AH; Ying SK; Lee CK; Chan TM
    Lupus; 2021 Jun; 30(7):1039-1050. PubMed ID: 33765901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Biomarker Panel in Proliferative Lupus Nephritis- Two-Dimensional Shotgun Proteomics.
    Ghasemi M; Kalantari S; Zubarev RA; Nafar M; Saei AA; Heidari SS; Baghestani AR; Samavat S
    Iran J Kidney Dis; 2021 Mar; 1(2):121-133. PubMed ID: 33764323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
    Martín-Penagos L; Fernández-Fresnedo G; Benito-Hernández A; Mazón J; de Cos M; Oviedo MV; San Segundo D; López-Hoyos M; Gómez-Román J; Ruiz JC; Rodrigo E
    Nefrologia (Engl Ed); 2021; 41(3):311-320. PubMed ID: 33741175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerulonephritis in AKI: From Pathogenesis to Therapeutic Intervention.
    Pesce F; Stea ED; Rossini M; Fiorentino M; Piancone F; Infante B; Stallone G; Castellano G; Gesualdo L
    Front Med (Lausanne); 2020; 7():582272. PubMed ID: 33738291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study.
    Fasano S; Coscia MA; Pierro L; Ciccia F
    Lupus; 2021 May; 30(6):991-997. PubMed ID: 33709836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy.
    Yiu WH; Chan KW; Chan LYY; Leung JCK; Lai KN; Tang SCW
    Front Physiol; 2021; 12():650888. PubMed ID: 33790807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM10-Mediated Ectodomain Shedding Is an Essential Driver of Podocyte Damage.
    Sachs M; Wetzel S; Reichelt J; Sachs W; Schebsdat L; Zielinski S; Seipold L; Heintz L; Müller SA; Kretz O; Lindenmeyer M; Wiech T; Huber TB; Lüllmann-Rauch R; Lichtenthaler SF; Saftig P; Meyer-Schwesinger C
    J Am Soc Nephrol; 2021 Jun; 32(6):1389-1408. PubMed ID: 33785583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrantly glycosylated IgG elicits pathogenic signaling in podocytes and signifies lupus nephritis.
    Bhargava R; Lehoux S; Maeda K; Tsokos MG; Krishfield S; Ellezian L; Pollak M; Stillman IE; Cummings RD; Tsokos GC
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33784256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy.
    Caravaca-Fontán F; Díaz-Encarnación M; Cabello V; Ariceta G; Quintana LF; Marco H; Barros X; Ramos N; Rodríguez-Mendiola N; Cruz S; Fernández-Juárez G; Rodríguez A; Pérez de José A; Rabasco C; Rodado R; Fernández L; Pérez Gómez V; Ávila A; Bravo L; Espinosa N; Allende N; Sanchez de la Nieta MD; Rodríguez E; Olea T; Melgosa M; Huerta A; Miquel R; Mon C; Fraga G; de Lorenzo A; Draibe J; Cano-Megías M; González F; Shabaka A; López-Rubio ME; Fenollosa MÁ; Martín-Penagos L; Da Silva I; Alonso Titos J; Rodríguez de Córdoba S; Goicoechea de Jorge E; Praga M
    Nephrol Dial Transplant; 2022 Jun; 37(7):1270-1280. PubMed ID: 33779754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.